Nextstellis | Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

The active film-coated tablet is pink, 6 mm diameter, round, biconvex with a drop-shaped logo embossed on one side.
Each pink active tablet contains 3 mg drospirenone and estetrol monohydrate 15 mg equivalent to 14.2 mg estetrol.
The placebo film-coated tablet is white to off-white, 6 mm diameter, round, biconvex with a drop-shaped logo embossed on one side.
Each white placebo tablet does not contain active substances.
Excipient with known effect: Each pink active tablet contains 40 mg lactose monohydrate.
Each white placebo tablet contains 68 mg lactose monohydrate.
Excipients/Inactive Ingredients: Pink active film-coated tablets: Tablet core: Lactose monohydrate, Sodium starch glycolate, Maize starch, Povidone K30, Magnesium stearate (E470b).
Tablet coating: Hypromellose (E464), Hydroxypropylcellulose (E463), Talc (E553b), Hydrogenated cottonseed oil, Titanium dioxide (E171), Iron oxide red (E172).
White placebo film-coated tablets: Tablet core: Lactose monohydrate, Maize starch, Magnesium stearate (E470b).
Tablet coating: Hypromellose (E464), Hydroxypropylcellulose (E463), Talc (E553b), Hydrogenated cottonseed oil, Titanium dioxide (E171).

Nextstellis Description

Manufacturer:

OLIC

Distributor:

DKSH